BioCryst Pharmaceuticals, Inc.

NasdaqGS:BCRX Stock Report

Market Cap: US$1.3b

BioCryst Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:BCRX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 May 24BuyUS$49,996Alan LevinIndividual7,861US$6.36
24 May 24BuyUS$16,000Stephen AselageIndividual2,500US$6.40
20 May 24BuyUS$93,750Vincent MilanoIndividual15,000US$6.25
20 May 24BuyUS$31,900Nancy HutsonIndividual5,000US$6.38
14 May 24BuyUS$202,191Anthony DoyleIndividual36,300US$5.57
14 May 24BuyUS$175,800Helen ThackrayIndividual30,000US$5.86
13 May 24BuyUS$27,650Alane BarnesIndividual5,000US$5.53
13 May 24BuyUS$164,100Charles GayerIndividual30,000US$5.47
13 May 24BuyUS$120,451Steven K. GalsonIndividual21,940US$5.49
13 May 24BuyUS$166,500Jon StonehouseIndividual30,000US$5.55
15 Jun 23SellUS$31,920A. SandersIndividual4,000US$7.98
14 Jun 23SellUS$103,443Nancy HutsonIndividual12,866US$8.04

Insider Trading Volume

Insider Buying: BCRX insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BCRX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,6570.00177%
Individual Insiders2,065,3811%
Hedge Funds13,050,0006.32%
General Public22,146,33110.7%
Institutions169,111,71981.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.2%.


Top Shareholders

Top 25 shareholders own 66.22% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.94%
BlackRock, Inc.
18,440,729US$119.1m-1.29%no data
8.57%
The Vanguard Group, Inc.
17,676,767US$114.2m-0.49%no data
8.47%
State Street Global Advisors, Inc.
17,477,344US$112.9m36.8%no data
6.32%
Avoro Capital Advisors LLC
13,050,000US$84.3m0%1.09%
4.91%
Baker Bros. Advisors LP
10,126,176US$65.4m0%0.74%
3.16%
Kynam Capital Management, LP
6,527,491US$42.2m41.9%3.62%
2.42%
Deerfield Management Company, L.P. Series C
4,995,000US$32.3m10%0.62%
2.13%
Geode Capital Management, LLC
4,400,271US$28.4m3.28%no data
1.86%
Rp Management, Llc, Asset Management Arm
3,846,154US$24.8m0%9.39%
1.69%
Rock Springs Capital Management LP
3,496,256US$22.6m6.91%0.63%
1.67%
GW&K Investment Management, LLC
3,453,908US$22.3m47.8%0.2%
1.66%
Alkeon Capital Management, LLC
3,421,700US$22.1m145%0.16%
1.64%
Braidwell LP
3,379,577US$21.8m-40.9%1.36%
1.4%
Fisher Asset Management, LLC
2,884,619US$18.6m0%0.01%
1.27%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
2,611,545US$16.9m-24.5%no data
1.2%
Two Sigma Advisers, LP
2,473,412US$16.0m9.06%0.04%
1.13%
Columbia Management Investment Advisers, LLC
2,335,191US$15.1m92.5%no data
1.1%
Citigroup Inc.,Banking and Securities Investments
2,274,775US$14.7m90.5%0.01%
1.07%
Norges Bank Investment Management
2,216,612US$14.3m0%no data
1.04%
Rice Hall James & Associates, LLC
2,151,545US$13.9m-2.08%0.82%
1.02%
Cutter Capital Management, LP
2,105,459US$13.6m38.4%5.69%
0.89%
Stifel Asset Management Corp.
1,843,936US$11.9m-0.01%0.01%
0.89%
FMR LLC
1,833,831US$11.8m-32.5%no data
0.89%
Millennium Management LLC
1,830,169US$11.8m9.19%0.01%
0.87%
Northern Trust Global Investments
1,805,175US$11.7m-2.25%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.